التفاصيل البيبلوغرافية
| العنوان: |
The impact of SETBP1 mutations in neurological diseases and cancer. |
| المؤلفون: |
Kohyanagi, Naoki, Ohama, Takashi |
| المصدر: |
Genes to Cells; Sep2023, Vol. 28 Issue 9, p629-641, 13p |
| مصطلحات موضوعية: |
NEUROLOGICAL disorders, GENETIC mutation, MYELODYSPLASTIC syndromes, DISABILITIES, CANCER prognosis |
| مستخلص: |
SE translocation (SET) is a cancer‐promoting factor whose expression is upregulated in many cancers. High SET expression positively correlates with a poor cancer prognosis. SETBP1 (SET‐binding protein 1/SEB/MRD29), identified as SET‐binding protein, is the causative gene of Schinzel–Giedion syndrome, which is characterized by severe intellectual disability and a distorted facial appearance. Mutations in these genetic regions are also observed in some blood cancers, such as myelodysplastic syndromes, and are associated with a poor prognosis. However, the physiological role of SETBP1 and the molecular mechanisms by which the mutations lead to disease progression have not yet been fully elucidated. In this review, we will describe the current epidemiological data on SETBP1 mutations and shed light on the current knowledge about the SET‐dependent and ‐independent functions of SETBP1. [ABSTRACT FROM AUTHOR] |
|
Copyright of Genes to Cells is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder